Piramal Pharma Strengthens Future Ready Operations with 22.6% Emissions Reduction, 41% Renewable Energy and Zero USFDA OAI Observations

Positive

AI Analysis

Summary

Piramal Pharma Limited announced a 22.6% reduction in emissions, 41% renewable energy usage, and zero USFDA OAI observations, marking a milestone in its SBTi-approved decarbonization efforts.

Importance:2/10

Sentiment:

0.60

ESGsustainabilityemissions_reductionrenewable_energyregulatory_complianceoperations

Related Companies

$DERM $GBCYD $FVNNU

Read the original article

Published by PR Newswire Biotech on August 26, 2026 2:49 PM

Read Original